Secteur Shenzhen Salubris Pharmaceuticals Co., Ltd.

Actions

002294

CNE100000FW8

Produits pharmaceutiques

Cours en clôture Shenzhen S.E. 10/07/2026 Varia. 5j. Varia. 1 janv.
37,13 CNY +5,45% Graphique intraday de Shenzhen Salubris Pharmaceuticals Co., Ltd. +1,89% -25,07%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
+5,45%+1,89%+17,99%-40,94%-25,07%-18,02%+13,55%+25,86%+36,96% 5,78 Md
-0,17%+3,45%+8,80%+12,72%+12,55%+15,94%+86,88%+189,79%+148,94% 48,73 Md
+1,04%-3,54%+8,86%+2,33%+26,06%+67,29%+114,44%+159,87%+131,33% 35,82 Md
-0,13%-1,14%+4,57%+17,56%-4,76%-3,51%+41,03%+49,97%+176,65% 12,2 Md
-0,71%+4,64%+4,09%+27,55%+25,86%+17,61%+97,65%+79,67%+219,40% 12,11 Md
+0,76%+1,75%+2,34%+11,02%+29,06%+34,02%+123,93%+144,86%+347,86% 9,11 Md
-0,86%+1,08%+9,69%-4,60%+11,76%+53,57%-3,92%-0,90%-38,56% 7,09 Md
+0,75%-0,17%+2,11%-2,50%+22,55%+17,95%+45,66%+46,19%+109,97% 7 Md
+0,69%+3,96%+3,32%+5,25%+12,17%+25,52%+231,22%+243,14%+173,07% 6,7 Md
+1,24%+0,10%+10,98%+21,72%+20,94%+27,46%+135,60%+131,97%+208,07% 4,33 Md
-2,21%-6,32%+0,74%+10,17%+25,94%+25,56%-17,81%-12,48%-60,98% 4 Md
+1,68%+12,05%+26,20%-11,56%+1,00%+12,99%+58,25%+2,63% - 3,9 Md
-1,12%-7,14%-4,07%+32,20%+25,20%+5,46%+631,74%+235,28%+90,42% 3,12 Md
+3,47%-2,16%-17,69%-60,40%-14,15%+22,00%+293,69%+275,89%+1 791,94% 2,99 Md
-1,87%-2,77%-5,15%-3,73%+3,51%-12,74%+29,89% - - 2,75 Md
+0,30%+6,23%+7,81%-1,01%+6,51%+34,14%+81,32%+25,75%+87,85% 2,85 Md
-0,15%-1,96%-3,28%-9,92%-8,40%-17,69%+32,99%+177,65%+696,32% 2,77 Md
+0,49%-1,59%+9,06%-15,03%-18,68%-32,03%+45,24%+25,48%+23,73% 2,71 Md
+5,05%+0,18%+12,48%+10,88%+18,48%-22,20%+39,77%+93,34% - 2,5 Md
-1,34%+1,50%+14,52%+55,50%+40,42%+27,23%+228,85%+292,29%+1 123,80% 2,09 Md
Moyenne +0,62%-0,15%+5,67%+2,86%+10,55%+14,03%+115,50%+115,07%+309,81% 8,93 Md
Moyenne pondérée par Capi. +0,43%+0,31%+7,02%+6,56%+14,35%+25,33%+99,48%+133,87%+193,03%
Pharmacies génériques
  1. Bourse
  2. Actions
  3. Action 002294
  4. Secteur Shenzhen Salubris Pharmaceuticals Co., Ltd.